Singapore markets closed

Vivos Inc. (RDGL)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1784+0.0156 (+9.57%)
As of 11:33AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.1628
Open0.1740
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.1700 - 0.1959
52-week range0.0412 - 0.2420
Volume828,560
Avg. volume1,332,291
Market cap69.549M
Beta (5Y monthly)1.05
PE ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings date02 Aug 2024 - 06 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation

    Richland WA, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce that the Food and Drug Administration has granted RadioGel Precision Radionuclide Therapy the designation as a Breakthrough Device pursuant to the FDA’s Breakthrough Devices Program. Dr. Mike Korenko stated “We are pleased with the FDA’s decision to grant Breakthrough Device Designation following our recent data submissions. The FDA did a very thorough review. The analysis in our Risk Manage